A comparison of the efficacy of cyclizine and perhenazine in reducing the emetic effects of morphine and pethidine.
1 The ability of cyclizine (50 mg) and perphenazine (2.5 and 5.0 mg) to counteract the emetic effects of pethidine (100 mg) and morphine (10 and 15 mg) was compared in women undergoing a standard minor operation with a standard anaesthetic. 2 Perphenazine (5.0 mg) was as effective an anti-emetic as cyclizine (50 mg) and both were more effective than perphenazine (2.5 mg). 3 The reduction in vomiting and nausea by cyclizine (50 mg) and perphenazine (5 mg) was approximately the same following pethidine (100 mg) and morphine (10 mg) but much less against the larger dose of morphine. 4 Both anti-emetics had a rapid onset of action but their anti-emetic activity did not last as long as the emetic effect of morphine. 5 Perphenazine (5 mg) was accompanied by an unacceptably high incidence of restlessness. 6 In clinical practice cyclizine (50 mg) is preferred to perphenazine (5 mg) as an anti-emetic.
D000932:Antiemetics; D003501:Cyclizine / Q000494:pharmacology*; D004341:Drug Evaluation; D006801:Humans; D008614:Meperidine / Q000037:antagonists & inhibitors*; D009020:Morphine / Q000037:antagonists & inhibitors*; D010546:Perphenazine / Q000009:adverse effects / Q000494:pharmacology*; D011229:Preanesthetic Medication / Q000009:adverse effects
D000932:Antiemetics; D009020:Morphine; D008614:Meperidine; D010546:Perphenazine; D003501:Cyclizine